首页> 外文期刊>Medical science monitor : >Cytomegalovirus disease in neonates and infants--clinical presentation, diagnostic and therapeutic problems--own experience.
【24h】

Cytomegalovirus disease in neonates and infants--clinical presentation, diagnostic and therapeutic problems--own experience.

机译:新生儿和婴儿的巨细胞病毒病-临床表现,诊断和治疗问题-自己的经验。

获取原文
           

摘要

BACKGROUND: The aim of the study was to present diagnostic problems, different clinical presentations and results of treatment of cytomegalovirus infections in neonates and infants. MATERIAL/METHODS: The study was carried out in a group of 31 children from 10 days to 12 months of age (17 boys, 14 girls). The diagnosis was based on serological investigations (presence of specific IgM antibodies and/or increasing titer of IgG antibodies), presence of intermediate or early CMV antigen in peripheral blood leukocytes or positive blood or urine PCR results. The treatment of 25 cases involved intravenous administration of gancyclovir at 5-7 mg/kg daily doses for 14-21 days. In 1 case, hyperimmunized anti-CMV serum - Cytotect was used. RESULTS: The most common clinical symptoms were jaundice, hepato- and splenomegaly. Clinical investigations demonstrated increased aminotransferese activity and the signs of cholestasis. Other frequent findings included anemia, leukocytosis with atypical lymphocyte forms present, as well as thrombocytopenia. In majority treated patients, rapid regression of the clinical symptoms and normalization of transaminases activity was observed. Good outcome of the therapy was confirmed by immunological investigations. The effects of the terapy were similar irrespective of the dose and duration of gancyclovir treatment. The tolerance of the drug was good - no indications for discontinuation of the treatment were observed in any of the patients. CONCLUSIONS: The clinical presentations of cytomegalovirus disease in infants are varied, the diagnosis of the disease should be considered in children with persistent jaundice, especially if it is accompanied by hepatomegaly and increased aminotransferase activity or signs of cholestasis. Despite relatively good tolerance of the drug by children, the patients should be monitored for possible side effects, especially myelo- and nephrotoxic.
机译:背景:这项研究的目的是提出诊断问题,不同的临床表现以及新生儿和婴儿巨细胞病毒感染的治疗结果。材料/方法:这项研究是针对一组年龄在10天至12个月的31名儿童(男17名,女14名)进行的。该诊断基于血清学调查(特异性IgM抗体和/或IgG抗体滴度增加),外周血白细胞中存在中间或早期CMV抗原或血液或尿液PCR阳性结果。 25例患者的治疗包括以5-7 mg / kg日剂量静脉注射更昔洛韦,持续14-21天。在1例中,使用了超免疫的抗CMV血清Cytotect。结果:最常见的临床症状是黄疸,肝肿大和脾肿大。临床研究表明转氨酶活性增加和胆汁淤积的迹象。其他常见发现包括贫血,存在非典型淋巴细胞形式的白细胞增多症以及血小板减少症。在大多数接受治疗的患者中,观察到临床症状迅速消退,转氨酶活性恢复正常。免疫学检查证实了该疗法的良好结果。无论更昔洛韦治疗的剂量和持续时间长短,其治疗效果均相似。药物的耐受性良好-在任何患者中均未观察到终止治疗的迹象。结论:婴儿巨细胞病毒病的临床表现各不相同,对于患有持续性黄疸的儿童,应考虑对该病的诊断,尤其是伴有肝肿大和氨基转移酶活性增加或胆汁淤积的迹象时。尽管儿童对药物的耐受性相对较好,但应监测患者的可能副作用,尤其是骨髓毒性和肾毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号